GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €26.93 million as of June 27, 2025. Its market cap has decreased by -19.39% in one year.

Market Cap

26.93M

Enterprise Value

43.57M

Revenue

2.63M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.20

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 26.93M, a decrease of -89.32%. That is a compound annual growth rate of -22.10%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	26.15M	-20.90%
Dec 31, 2024	33.05M	28.79%
Dec 29, 2023	25.66M	-83.46%
Dec 30, 2022	155.20M	-39.23%
Dec 31, 2021	255.38M	-16.09%
Dec 31, 2020	304.35M	275.09%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EssilorLuxottica Société anonyme	111.83B
Sanofi	101.92B
Sartorius Stedim Biotech	19.39B
bioMérieux	14.21B
Eurofins Scientific SE	10.85B
Ipsen	8.49B
Virbac	2.72B
emeis Société anonyme	1.82B

Market Cap Rankings